Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › AR › ROGERS › MERCY HOSPITAL ROGERS

MERCY HOSPITAL ROGERS

NPI: 1316902414 · ROGERS, AR 72758 · Interventional Pain Medicine Physician · NPI assigned 04/20/2006

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WILCHER, GRETA controls 14+ related entities in our dataset. Read more

$14.20M
Total Medicaid Paid
724,639
Total Claims
582,503
Beneficiaries
339
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialWILCHER, GRETA (CFO)
NPI Enumeration Date04/20/2006

Related Entities

Other providers sharing the same authorized official: WILCHER, GRETA

ProviderCityStateTotal Paid
MERCY CLINIC FORT SMITH COMMUNITIES FORT SMITH AR $24.10M
MERCY HOSPITAL FORT SMITH FORT SMITH AR $22.48M
MERCY HEALTH NORTHWEST ARKANSAS COMMUNITIES ROGERS AR $8.38M
MERCY CLINIC FORT SMITH COMMUNITIES FORT SMITH AR $2.28M
MERCY HOSPITAL ROGERS ROGERS AR $1.83M
MERCY CLINIC FORT SMITH COMMUNITIES FORT SMITH AR $1.62M
MERCY HEALTH NORTHWEST ARKANSAS COMMUNITIES ROGERS AR $318K
MERCY HOSPITAL FORT SMITH FORT SMITH AR $298K
MERCY HEALTH NORTHWEST ARKANSAS COMMUNITIES ROGERS AR $207K
MERCY HEALTH NORTHWEST ARKANSAS COMMUNITIES ROGERS AR $104K
MERCY HEALTH NORTHWEST ARKANSAS COMMUNITIES BELLA VISTA AR $86K
ST EDWARD MERCY FOUNDATION FORT SMITH AR $74K
MERCY HEALTH NORTHWEST ARKANSAS COMMUNITIES ROGERS AR $26K
MERCY HOSPITAL FORT SMITH FORT SMITH AR $127.47

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 116,450 $1.79M
2019 123,247 $2.02M
2020 95,716 $1.91M
2021 91,089 $2.00M
2022 95,283 $2.29M
2023 112,298 $2.44M
2024 90,556 $1.76M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 38,669 10,880 $1.61M
74177 Computed tomography, abdomen and pelvis; with contrast material 6,335 5,799 $825K
70450 Computed tomography, head or brain; without contrast material 6,848 6,231 $599K
80053 Comprehensive metabolic panel 28,167 23,354 $501K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 4,043 2,017 $499K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 5,642 4,125 $433K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 3,537 3,316 $399K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 6,566 5,228 $390K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 3,306 3,160 $357K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 45,982 35,975 $321K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 6,109 5,841 $279K
80048 Basic metabolic panel (calcium, ionized) 18,326 14,489 $274K
71275 Computed tomographic angiography, chest, with contrast material 1,614 1,508 $263K
36415 Collection of venous blood by venipuncture 19,650 14,370 $250K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 1,076 1,007 $238K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 675 629 $236K
72125 Computed tomography, cervical spine; without contrast material 1,978 1,821 $201K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 18,482 15,820 $180K
97530 Therapeutic activities, direct patient contact, each 15 minutes 8,770 2,900 $174K
59025 Fetal non-stress test 1,017 825 $174K
97161 3,013 2,824 $157K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 939 871 $145K
99283 Emergency department visit for the evaluation and management, moderate severity 2,634 2,222 $141K
93976 2,461 2,290 $135K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 3,142 2,865 $128K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 3,152 2,875 $128K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1,111 1,010 $126K
74176 Computed tomography, abdomen and pelvis; without contrast material 1,910 1,771 $122K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 5,003 4,268 $118K
71045 Radiologic examination, chest; single view 14,144 12,603 $115K
87086 Culture, bacterial; quantitative colony count, urine 13,923 12,527 $112K
71260 Computed tomography, thorax, diagnostic; with contrast material 864 812 $105K
87428 1,710 1,643 $104K
83880 4,559 4,075 $101K
87081 11,317 10,781 $96K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 453 444 $94K
84484 11,100 7,664 $90K
81025 9,923 8,937 $82K
87653 1,855 1,739 $81K
77067 Screening mammography, bilateral, including computer-aided detection 1,781 1,725 $81K
80306 4,958 4,442 $81K
99284 Emergency department visit for the evaluation and management, high severity 2,425 2,152 $79K
80050 General health panel 2,202 2,054 $77K
83690 11,274 9,877 $75K
71046 Radiologic examination, chest; 2 views 4,370 4,154 $73K
T1015 Clinic visit/encounter, all-inclusive 9,026 7,259 $72K
82947 4,769 3,049 $68K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 698 660 $68K
86901 3,392 2,979 $66K
70551 Magnetic resonance imaging, brain; without contrast material 350 325 $66K
81001 19,642 17,421 $65K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1,258 238 $62K
97001 1,965 1,829 $60K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 2,988 2,578 $56K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 805 724 $54K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 4,471 4,302 $52K
70498 354 329 $51K
82565 3,502 3,232 $50K
12001 256 242 $50K
80081 586 539 $50K
87070 4,359 3,986 $49K
70496 347 325 $49K
J2405 Injection, ondansetron hydrochloride, per 1 mg 17,228 14,292 $48K
76801 1,503 1,296 $47K
87077 5,760 5,297 $46K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1,402 1,302 $45K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 944 876 $44K
76705 Ultrasound, abdominal, real time with image documentation; limited 2,587 2,460 $43K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 157 143 $43K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 879 826 $40K
76830 Ultrasound, transvaginal 779 727 $39K
A9577 Injection, gadobenate dimeglumine (multihance), per ml 1,822 1,599 $39K
72141 179 171 $37K
82962 5,470 3,342 $35K
86140 7,335 6,008 $34K
73562 1,129 1,061 $34K
87186 5,741 5,278 $33K
80076 3,194 2,951 $33K
73630 1,263 1,192 $32K
83735 6,704 5,574 $32K
82803 1,959 1,725 $32K
71250 530 511 $32K
0240U 271 268 $32K
83605 3,284 2,905 $31K
87040 2,349 1,787 $30K
85610 9,879 8,522 $30K
72100 1,148 1,102 $29K
82077 2,071 1,796 $29K
93971 816 766 $29K
88305 Level IV - Surgical pathology, gross and microscopic examination 451 409 $28K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care 1,845 530 $27K
84443 Thyroid stimulating hormone (TSH) 2,480 2,294 $27K
94060 772 754 $27K
73610 1,288 1,222 $27K
86850 2,673 2,345 $27K
85379 2,931 2,721 $26K
97162 383 361 $26K
J2785 Injection, regadenoson, 0.1 mg 581 536 $25K
J0696 Injection, ceftriaxone sodium, per 250 mg 4,176 3,176 $25K
42820 Tonsillectomy and adenoidectomy; younger than age 12 86 79 $24K
73030 983 924 $24K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 927 872 $24K
81003 9,430 8,636 $24K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 597 524 $24K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 7,847 6,963 $24K
12011 105 101 $23K
J1650 Injection, enoxaparin sodium, 10 mg 1,170 792 $23K
45380 Colonoscopy, flexible; with biopsy, single or multiple 175 168 $23K
97165 502 469 $22K
84112 306 265 $22K
73130 902 863 $21K
84145 1,129 1,012 $21K
80143 1,180 1,066 $21K
84702 2,120 1,830 $20K
83655 1,332 1,294 $20K
80320 1,609 1,407 $19K
86900 3,278 2,874 $19K
80179 1,119 1,014 $19K
77063 Screening digital breast tomosynthesis, bilateral 1,781 1,725 $19K
80074 411 386 $18K
73110 806 743 $18K
76642 680 656 $17K
95810 Polysomnography; sleep staging with 4 or more additional parameters 166 160 $17K
11043 108 63 $17K
87147 1,885 1,745 $17K
70486 157 142 $17K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 410 398 $16K
J1815 Injection, insulin, per 5 units 1,423 1,053 $16K
J1885 Injection, ketorolac tromethamine, per 15 mg 7,858 6,385 $16K
93017 1,079 1,001 $14K
74018 665 620 $14K
83036 Hemoglobin; glycosylated (A1C) 2,427 2,247 $14K
J7030 Infusion, normal saline solution , 1000 cc 6,631 5,310 $14K
80061 Lipid panel 1,827 1,677 $13K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1,640 1,409 $13K
74022 553 520 $13K
87631 142 137 $12K
87807 1,001 954 $12K
94729 650 634 $12K
94726 646 632 $11K
87075 1,086 922 $11K
85652 4,994 3,973 $11K
85730 2,214 2,062 $11K
85027 1,774 1,393 $10K
90715 703 659 $10K
80329 916 783 $10K
87210 1,844 1,695 $9K
J2704 Injection, propofol, 10 mg 11,891 7,440 $9K
82550 1,601 1,205 $8K
76536 210 205 $8K
71020 589 548 $8K
87641 453 417 $8K
73502 217 209 $8K
62323 53 51 $7K
87205 2,168 1,917 $7K
87088 860 805 $7K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 715 672 $7K
87493 243 230 $7K
87899 729 584 $7K
84146 334 304 $7K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 72 72 $6K
93226 176 167 $6K
72040 214 206 $6K
83970 238 223 $5K
87634 62 61 $5K
J3010 Injection, fentanyl citrate, 0.1 mg 11,362 9,895 $5K
97003 256 234 $5K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 2,093 687 $5K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 1,186 399 $5K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 9,597 8,168 $5K
87340 395 369 $4K
71010 622 565 $4K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,549 1,033 $4K
J2250 Injection, midazolam hydrochloride, per 1 mg 6,751 5,950 $4K
77066 Tomosynthesis, mammo 72 63 $4K
87045 389 369 $4K
J0690 Injection, cefazolin sodium, 500 mg 3,256 2,695 $4K
86039 395 365 $3K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 31 30 $3K
12002 12 12 $3K
29125 15 15 $3K
36600 221 189 $3K
95811 25 24 $3K
77080 58 55 $3K
87046 391 370 $3K
96361 Intravenous infusion, hydration; each additional hour 103 91 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 427 402 $3K
86592 595 561 $3K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 187 171 $3K
93225 144 141 $2K
83516 202 178 $2K
87400 140 136 $2K
76770 62 60 $2K
99152 403 363 $2K
J2060 Injection, lorazepam, 2 mg 2,831 2,460 $2K
86762 138 130 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg 4,156 3,532 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 9,858 8,019 $2K
84439 214 191 $2K
73090 81 79 $2K
86038 157 148 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 1,031 888 $2K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 128 122 $2K
80164 218 185 $2K
84156 564 482 $2K
82150 292 263 $2K
82570 437 404 $2K
82010 273 222 $2K
76700 Ultrasound, abdominal, real time with image documentation; complete 44 41 $2K
94761 552 497 $2K
82784 213 194 $2K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 40 36 $2K
93975 28 27 $2K
73560 30 30 $2K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 1,147 1,004 $2K
51798 14 14 $1K
94760 269 177 $1K
J1170 Injection, hydromorphone, up to 4 mg 3,985 3,148 $1K
96375 Therapeutic injection; each additional sequential IV push 7,202 5,864 $1K
J2270 Injection, morphine sulfate, up to 10 mg 4,640 3,910 $1K
82140 234 188 $1K
A9270 Non-covered item or service 4,298 3,064 $1K
J0780 Injection, prochlorperazine, up to 10 mg 2,712 2,378 $1K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 138 134 $945.16
J7120 Ringers lactate infusion, up to 1000 cc 3,889 3,343 $929.59
97597 51 37 $915.42
86003 13 12 $887.74
74000 54 51 $880.50
73590 37 37 $860.15
P9612 Catheterization for collection of specimen, single patient, all places of service 53 52 $838.25
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 26 25 $800.83
0202U Oncology (prostate), multianalyte, gene expression profiling 2,144 2,077 $778.96
73070 44 41 $770.47
82607 145 131 $756.90
86803 56 51 $749.94
C1769 Guide wire 15 14 $746.59
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 1,171 982 $706.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 225 196 $697.39
J1644 Injection, heparin sodium, per 1000 units 1,990 1,196 $696.95
73140 31 27 $616.39
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 55 39 $552.62
86481 12 12 $552.47
82397 31 27 $545.26
87522 Neg quan hep c or qual rna 12 12 $534.79
84100 193 154 $530.94
86200 56 53 $530.37
82728 49 46 $486.50
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 65 64 $478.98
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 175 165 $436.08
71101 12 12 $425.32
87328 38 38 $425.17
87329 38 38 $416.85
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 37 36 $401.21
89055 37 37 $398.00
84402 12 12 $386.69
84703 28 28 $367.75
74230 13 12 $367.05
82105 31 27 $364.77
84403 12 12 $358.70
72170 17 14 $344.36
C1887 Catheter, guiding (may include infusion/perfusion capability) 12 12 $340.52
86696 12 12 $311.50
J2765 Injection, metoclopramide hcl, up to 10 mg 636 569 $310.79
J3370 Injection, vancomycin hcl, 500 mg 104 71 $308.01
0353U 376 357 $303.24
83540 107 101 $286.75
92611 13 12 $281.22
83615 48 46 $280.47
J3475 Injection, magnesium sulfate, per 500 mg 214 174 $268.14
82746 81 72 $255.12
82533 14 13 $225.30
83520 15 15 $221.88
87425 16 15 $180.18
Q3014 Telehealth originating site facility fee 113 101 $169.55
S0164 Injection, pantoprazole sodium, 40 mg 318 260 $156.67
86695 12 12 $152.71
97014 1,142 318 $144.15
82247 22 15 $143.40
86923 14 12 $135.80
82330 15 13 $132.09
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 15 13 $130.00
87185 29 25 $128.82
J0360 Injection, hydralazine hcl, up to 20 mg 208 181 $128.06
J0171 Injection, adrenalin, epinephrine, 0.1 mg 140 122 $125.42
85014 31 26 $112.67
80177 14 13 $108.54
87640 12 12 $101.34
S0028 Injection, famotidine, 20 mg 470 404 $100.08
93242 12 12 $88.02
J2370 Injection, phenylephrine hcl, up to 1 ml 601 381 $75.75
J2919 Injection, methylprednisolone sodium succinate, 5 mg 153 125 $72.88
82248 15 12 $71.70
85018 15 12 $68.52
J1940 Injection, furosemide, up to 20 mg 55 42 $54.35
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2,486 1,915 $49.59
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 94 63 $49.05
96376 1,719 1,341 $43.87
J0694 Injection, cefoxitin sodium, 1 gm 17 12 $43.52
84550 14 14 $42.90
G0378 Hospital observation service, per hour 235 214 $41.78
36416 18 13 $40.00
J3480 Injection, potassium chloride, per 2 meq 38 27 $37.57
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 417 358 $23.65
J2550 Injection, promethazine hcl, up to 50 mg 47 46 $21.76
76981 12 12 $19.48
J3360 Injection, diazepam, up to 5 mg 29 26 $19.36
J1596 Injection, glycopyrrolate, 0.1 mg 142 119 $18.09
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 710 539 $17.60
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 761 675 $11.53
J2300 Injection, nalbuphine hydrochloride, per 10 mg 27 25 $11.40
J0687 Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg 55 39 $11.00
J2470 Injection, pantoprazole sodium, 40 mg 41 31 $10.38
S0020 Injection, bupivicaine hydrochloride, 30 ml 141 134 $8.74
97010 711 216 $8.37
J1920 Injection, labetalol hydrochloride, 5 mg 28 25 $7.68
J2175 Injection, meperidine hydrochloride, per 100 mg 217 205 $2.19
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 283 248 $0.26
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 253 224 $0.20
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg 74 59 $0.00
S0077 Injection, clindamycin phosphate, 300 mg 13 13 $0.00
J1171 Injection, hydromorphone, 0.1 mg 85 46 $0.00
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg 16 14 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 31 26 $0.00
J1956 Injection, levofloxacin, 250 mg 12 12 $0.00
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg 44 41 $0.00
97116 19 12 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 138 137 $0.00
J7050 Infusion, normal saline solution, 250 cc 142 110 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 37 30 $0.00
J8540 Dexamethasone, oral, 0.25 mg 53 51 $0.00
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose 247 238 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 220 167 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 92 71 $0.00
99153 Mod sedat endo service >5yrs 12 12 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 35 29 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 153 143 $0.00
97016 38 12 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 13 13 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 41 20 $0.00